Patents by Inventor Thomas Edward D'Ambra

Thomas Edward D'Ambra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240108648
    Abstract: One aspect of the present application relates to a pharmaceutical composition comprising a sulfated glycosaminoglycan having an average molecular weight ranging from 3,000 to 15,000 Daltons, a skin penetrating agent, where the skin penetrating agent promotes transdermal penetration of the sulfated glycosaminoglycan when applied to intact skin surfaces, and a pharmaceutical carrier for topical application, where the pharmaceutical carrier is mixed with the sulfated glycosaminoglycan and the skin penetrating agent. This composition is useful in carrying out a method of treating a subject for pain, joint stiffness, soft tissue injury, connective tissue disorders, and/or muscle soreness.
    Type: Application
    Filed: September 28, 2023
    Publication date: April 4, 2024
    Inventors: Thomas Michael VAUGHN, Joshua Alan HARRISON, Karl F. POPP, David J. FAIRFAX, Thomas Edward D'AMBRA, John QUINN
  • Patent number: 5817651
    Abstract: 2-R.sub.2 --R.sub.4 -substituted-3-R.sub.3 --CO-1-?(C-attached-N-heteryl)-(Alk) .sub.n !-1H-indoles useful as analgesic, anti-rheumatic, anti-inflammatory or anti-glaucoma agents.
    Type: Grant
    Filed: January 14, 1997
    Date of Patent: October 6, 1998
    Assignee: Sanofi
    Inventors: Thomas Edward D'Ambra, Edward Richard Bacon, Malcolm Rice Bell, Philip Michael Carabateas, Michael Allen Eissenstat, Virendra Kumar, John Peter Mallamo, Susan Jean Ward